EMBO Molecular Medicine (Jun 2014)

IgE actions on CD4+ T cells, mast cells, and macrophages participate in the pathogenesis of experimental abdominal aortic aneurysms

  • Jing Wang,
  • Jes S Lindholt,
  • Galina K Sukhova,
  • Michael A Shi,
  • Mingcan Xia,
  • Han Chen,
  • Meixiang Xiang,
  • Aina He,
  • Yi Wang,
  • Na Xiong,
  • Peter Libby,
  • Jian‐An Wang,
  • Guo‐Ping Shi

DOI
https://doi.org/10.15252/emmm.201303811
Journal volume & issue
Vol. 6, no. 7
pp. 952 – 969

Abstract

Read online

Abstract Immunoglobulin E (IgE) activates mast cells (MCs). It remains unknown whether IgE also activates other inflammatory cells, and contributes to the pathogenesis of abdominal aortic aneurysms (AAAs). This study demonstrates that CD4+ T cells express IgE receptor FcεR1, at much higher levels than do CD8+ T cells. IgE induces CD4+ T‐cell production of IL6 and IFN‐γ, but reduces their production of IL10. FcεR1 deficiency (Fcer1a−/−) protects apolipoprotein E‐deficient (Apoe−/−) mice from angiotensin‐II infusion‐induced AAAs and reduces plasma IL6 levels. Adoptive transfer of CD4+ T cells (but not CD8+ T cells), MCs, and macrophages from Apoe−/− mice, but not those from Apoe−/−Fcer1a−/− mice, increases AAA size and plasma IL6 in Apoe−/−Fcer1a−/− recipient mice. Biweekly intravenous administration of an anti‐IgE monoclonal antibody ablated plasma IgE and reduced AAAs in Apoe−/− mice. Patients with AAAs had significantly higher plasma IgE levels than those without AAAs. This study establishes an important role of IgE in AAA pathogenesis by activating CD4+ T cells, MCs, and macrophages and supports consideration of neutralizing plasma IgE in the therapeutics of human AAAs.

Keywords